TY - JOUR
T1 - Differences in Ventilation Management and Outcomes between the Two First Waves of the COVID-19 Pandemic—A Comparison between Two Nationwide Observational Studies in The Netherlands
AU - on behalf of the PRoVENT–COVID
AU - PRoAcT-COVID Investigators
AU - Hol, Liselotte
AU - Schultz, Marcus J.
AU - Martin-Loeches, Ignacio
AU - van Meenen, David M.P.
AU - Serpa Neto, Ary
AU - Paulus, Frederique
N1 - Funding Information: PRoVENT–COVID and PRoAcT-COVID were funded by the Amsterdam UMC, location AMC, Amsterdam, the Netherlands, and by Zorgonderzoek Medische Wetenschappen (ZonMw), a collaboration between ‘Zorgonderzoek Nederland’ and ‘Medical Sciences of the Netherlands organization for Scientific Research’ (NWO-MW) (Number 10430102110008). The funder had no role in the design of the study, in the collection, analysis and interpretation of the data. The funder had no role in drafting the manuscript or in the decision to submit this manuscript. Publisher Copyright: © 2023 by the authors.
PY - 2023/7/5
Y1 - 2023/7/5
N2 - The aim of this analysis was to compare ventilation management and outcomes in invasively ventilated patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19) between the first and second wave in the Netherlands. This is a post hoc analysis of two nationwide observational COVID-19 studies conducted in quick succession. The primary endpoint was ventilation management. Secondary endpoints were tracheostomy use, duration of ventilation, intensive care unit (ICU) and hospital length of stay (LOS), and mortality. We used propensity score matching to control for observed confounding factors. This analysis included 1122 patients from the first and 568 patients from the second wave. Patients in the second wave were sicker, had more comorbidities, and had worse oxygenation parameters. They were ventilated with lower positive end-expiratory pressure and higher fraction inspired oxygen, had a lower oxygen saturation, received neuromuscular blockade more often, and were less often tracheostomized. Duration of ventilation was shorter, but mortality rates were similar. After matching, the fraction of inspired oxygen was lower in the second wave. In patients with acute hypoxemic respiratory failure due to COVID-19, aspects of respiratory care and outcomes rapidly changed over the successive waves.
AB - The aim of this analysis was to compare ventilation management and outcomes in invasively ventilated patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19) between the first and second wave in the Netherlands. This is a post hoc analysis of two nationwide observational COVID-19 studies conducted in quick succession. The primary endpoint was ventilation management. Secondary endpoints were tracheostomy use, duration of ventilation, intensive care unit (ICU) and hospital length of stay (LOS), and mortality. We used propensity score matching to control for observed confounding factors. This analysis included 1122 patients from the first and 568 patients from the second wave. Patients in the second wave were sicker, had more comorbidities, and had worse oxygenation parameters. They were ventilated with lower positive end-expiratory pressure and higher fraction inspired oxygen, had a lower oxygen saturation, received neuromuscular blockade more often, and were less often tracheostomized. Duration of ventilation was shorter, but mortality rates were similar. After matching, the fraction of inspired oxygen was lower in the second wave. In patients with acute hypoxemic respiratory failure due to COVID-19, aspects of respiratory care and outcomes rapidly changed over the successive waves.
KW - COVID-19
KW - complications
KW - coronavirus disease 2019
KW - invasive ventilation
KW - ventilation management
UR - http://www.scopus.com/inward/record.url?scp=85165198861&partnerID=8YFLogxK
U2 - https://doi.org/10.3390/jcm12134507
DO - https://doi.org/10.3390/jcm12134507
M3 - Article
C2 - 37445542
SN - 2077-0383
VL - 12
JO - Journal of clinical medicine
JF - Journal of clinical medicine
IS - 13
M1 - 4507
ER -